AUD 0.35
(-4.17%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2022 | 147.44 Million AUD | 44.32% |
2021 | 102.16 Million AUD | 24.55% |
2020 | 82.03 Million AUD | 76.04% |
2019 | 46.59 Million AUD | 14.94% |
2018 | 40.54 Million AUD | -13.74% |
2017 | 46.99 Million AUD | 34.42% |
2016 | 34.96 Million AUD | -17.84% |
2015 | 42.55 Million AUD | 37.34% |
2014 | 30.98 Million AUD | 22.09% |
2013 | 25.37 Million AUD | -22.66% |
2012 | 32.81 Million AUD | -21.14% |
2011 | 41.61 Million AUD | -27.81% |
2010 | 57.64 Million AUD | 203.19% |
2009 | 19.01 Million AUD | 663.62% |
2008 | 2.48 Million AUD | -11.75% |
2007 | 2.82 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2022 Q2 | 86 Million AUD | 0.0% |
2022 Q4 | 147.44 Million AUD | 0.0% |
2022 FY | 147.44 Million AUD | 44.32% |
2021 Q4 | 102.16 Million AUD | 0.0% |
2021 FY | 102.16 Million AUD | 24.55% |
2021 Q2 | 120.2 Million AUD | 0.0% |
2020 Q4 | 82.03 Million AUD | 0.0% |
2020 Q2 | 76.47 Million AUD | 0.0% |
2020 FY | 82.03 Million AUD | 76.04% |
2019 Q2 | 42.95 Million AUD | 0.0% |
2019 Q4 | 46.59 Million AUD | 0.0% |
2019 FY | 46.59 Million AUD | 14.94% |
2018 Q2 | 48.23 Million AUD | 0.0% |
2018 Q4 | 40.54 Million AUD | 0.0% |
2018 FY | 40.54 Million AUD | -13.74% |
2017 Q2 | 37.04 Million AUD | 0.0% |
2017 FY | 46.99 Million AUD | 34.42% |
2017 Q4 | 46.99 Million AUD | 0.0% |
2016 Q2 | 38.15 Million AUD | 0.0% |
2016 Q3 | 35.35 Million AUD | -7.35% |
2016 FY | 34.96 Million AUD | -17.84% |
2016 Q4 | 34.96 Million AUD | -1.11% |
2015 Q2 | 48.24 Million AUD | 0.0% |
2015 Q4 | 42.55 Million AUD | 0.0% |
2015 FY | 42.55 Million AUD | 37.34% |
2014 Q2 | 39.31 Million AUD | 0.0% |
2014 Q4 | 30.98 Million AUD | 0.0% |
2014 FY | 30.98 Million AUD | 22.09% |
2013 FY | 25.37 Million AUD | -22.66% |
2013 Q2 | 32.81 Million AUD | 0.0% |
2013 Q4 | 25.37 Million AUD | 0.0% |
2012 Q2 | 32.34 Million AUD | 0.0% |
2012 FY | 32.81 Million AUD | -21.14% |
2012 Q4 | 32.81 Million AUD | 0.0% |
2011 FY | 41.61 Million AUD | -27.81% |
2011 Q4 | 41.61 Million AUD | 0.0% |
2010 FY | 57.64 Million AUD | 203.19% |
2009 FY | 19.01 Million AUD | 663.62% |
2008 FY | 2.48 Million AUD | -11.75% |
2007 FY | 2.82 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
EZZ Life Science Holdings Limited | 25.55 Million AUD | -477.055% |
Anatara Lifesciences Ltd | 1.67 Million AUD | -8721.769% |
Zelira Therapeutics Limited | 5.18 Million AUD | -2744.629% |
Biome Australia Limited | 8.27 Million AUD | -1681.476% |
Patrys Limited | 4.16 Million AUD | -3443.101% |
Orthocell Limited | 26.61 Million AUD | -454.003% |
Imugene Limited | 151.39 Million AUD | 2.608% |
Noxopharm Limited | 6.78 Million AUD | -2073.559% |
PYC Therapeutics Limited | 91.23 Million AUD | -61.608% |
Chimeric Therapeutics Limited | 15.27 Million AUD | -865.413% |
Prescient Therapeutics Limited | 20.39 Million AUD | -623.043% |
Proteomics International Laboratories Limited | 10.87 Million AUD | -1255.839% |
Cynata Therapeutics Limited | 8.38 Million AUD | -1657.796% |
CSL Limited | 56.93 Billion AUD | 99.741% |
Arovella Therapeutics Limited | 13.28 Million AUD | -1009.917% |
Bio-Gene Technology Limited | 3.15 Million AUD | -4566.713% |
Clinuvel Pharmaceuticals Limited | 231.12 Million AUD | 36.203% |
Starpharma Holdings Limited | 36.81 Million AUD | -300.524% |
Nanollose Limited | 241.95 Thousand AUD | -60841.674% |
Memphasys Limited | 12.43 Million AUD | -1086.221% |
Invex Therapeutics Ltd | 6.12 Million AUD | -2309.277% |
NeuroScientific Biopharmaceuticals Limited | 5.43 Million AUD | -2612.517% |
Amplia Therapeutics Limited | 14.84 Million AUD | -893.25% |
Botanix Pharmaceuticals Limited | 112.46 Million AUD | -31.107% |
Island Pharmaceuticals Limited | 2.56 Million AUD | -5649.684% |
Race Oncology Limited | 20.22 Million AUD | -628.914% |
Nyrada Inc. | 5.9 Million AUD | -2396.063% |
Telix Pharmaceuticals Limited | 398.3 Million AUD | 62.981% |
Dimerix Limited | 32.07 Million AUD | -359.65% |
PharmAust Limited | 11.12 Million AUD | -1225.402% |
Clarity Pharmaceuticals Ltd | 154.62 Million AUD | 4.644% |
Alterity Therapeutics Limited | 19.22 Million AUD | -667.015% |
BTC Health Limited | 5.14 Million AUD | -2763.751% |
Acrux Limited | 8.96 Million AUD | -1545.085% |
Neuren Pharmaceuticals Limited | 247.97 Million AUD | 40.538% |
Biotron Limited | 493.47 Thousand AUD | -29779.668% |
Tissue Repair Ltd | 19.38 Million AUD | -660.455% |
AdAlta Limited | 5.57 Million AUD | -2545.774% |
Radiopharm Theranostics Limited | 72.03 Million AUD | -104.687% |
Hexima Limited | 2.26 Million AUD | -6398.402% |
AnteoTech Limited | 9.38 Million AUD | -1471.753% |
Paradigm Biopharmaceuticals Limited | 27.39 Million AUD | -438.323% |
Recce Pharmaceuticals Ltd | 6.36 Million AUD | -2214.881% |
Avecho Biotechnology Limited | 7.31 Million AUD | -1914.52% |
Actinogen Medical Limited | 21.31 Million AUD | -591.863% |
Immuron Limited | 15.54 Million AUD | -848.227% |
Argenica Therapeutics Limited | 16.37 Million AUD | -800.311% |